Aflac (NYSE:AFL) Director Joseph Moskowitz Sells 600 Shares of Stock

Aflac Incorporated (NYSE:AFL – Get Free Report) Director Joseph Moskowitz sold 600 shares of the firm’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $124.99, for a total value of $74,994.00. Following the completion of the sale, the director directly owned 32,119 shares in the company, valued at $4,014,553.81. This trade represents a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Aflac Stock Performance

NYSE AFL opened at $126.41 on Friday. The firm’s fifty day moving average price is $118.29 and its two-hundred day moving average price is $116.57. The stock has a market cap of $62.52 billion, a PE ratio of 18.43, a PEG ratio of 1.79 and a beta of 0.55. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.11 and a current ratio of 0.11. Aflac Incorporated has a fifty-two week low of $105.76 and a fifty-two week high of $131.18.

Aflac (NYSE:AFL – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $2.43 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.63. The firm had revenue of $4.30 billion for the quarter, compared to analyst estimates of $4.12 billion. Aflac had a return on equity of 12.82% and a net margin of 21.24%. The business’s revenue for the quarter was down 31.0% on a year-over-year basis. During the same period last year, the firm posted $2.49 earnings per share. On average, equities analysts expect that Aflac Incorporated will post 7.29 EPS for the current fiscal year.

Aflac Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 1st. Stockholders of record on Wednesday, February 17th will be given a $0.64 dividend. This is an increase from Aflac’s previous quarterly dividend of $0.61. The ex-dividend date is Wednesday, February 17th. This represents a $2.56 dividend on an annualized basis and a dividend yield of 2.0%. Aflac’s dividend payout ratio is presently 35.57%.

Aflac News Roundup

Here’s some of the latest news about AFL:

  • Positive Sentiment: Aflac raised its quarterly dividend 4.9%, from $0.61 to $0.64 per share. The $2.56 annualized payout equates to a yield of about 2.0%; payment is scheduled for March 1, 2027, to shareholders of record February 17. Aflac dividend announcement
  • Neutral Sentiment: Major shareholder Post Holdings’ Japan entity sold 13,000 shares, while director Joseph Moskowitz sold 600. Both sales were made under pre-arranged Rule 10b5-1 plans; the sales are small relative to their remaining holdings and may not indicate a change in outlook.
  • Negative Sentiment: Analyst target increases still leave valuations below the recent market price, and ratings are cautious: Wells Fargo lifted its target to $124 but kept an “equal weight” rating; Mizuho raised its target to $117 while maintaining “underperform.” JPMorgan also raised its target, to $121 from $119. These targets may temper the positive dividend signal. Wells Fargo target update JPMorgan target update

Institutional Trading of Aflac

Several institutional investors have recently made changes to their positions in AFL. Meiji Yasuda Asset Management Co Ltd. bought a new position in Aflac during the second quarter valued at about $6,630,000. Atlas Wealth LLC purchased a new position in Aflac in the first quarter valued at about $1,802,000. Callan Family Office LLC bought a new position in shares of Aflac during the 2nd quarter valued at approximately $2,546,000. Tidal Investments LLC grew its position in shares of Aflac by 137.4% during the 2nd quarter. Tidal Investments LLC now owns 40,904 shares of the financial services provider’s stock valued at $4,796,000 after acquiring an additional 23,677 shares during the period. Finally, Fifth Third Bancorp increased its stake in shares of Aflac by 135.5% during the 1st quarter. Fifth Third Bancorp now owns 142,180 shares of the financial services provider’s stock worth $15,599,000 after purchasing an additional 81,803 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on AFL shares. Weiss Ratings raised Aflac from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Tuesday, November 3rd. JPMorgan Chase & Co. raised their target price on Aflac from $116.00 to $119.00 and gave the stock a “neutral” rating in a research note on Thursday, October 15th. Piper Sandler lifted their target price on Aflac from $138.00 to $143.00 and gave the stock an “overweight” rating in a report on Monday. TD Cowen reissued a “hold” rating and issued a $110.00 price target (up from $101.00) on shares of Aflac in a research note on Wednesday, July 22nd. Finally, Keefe, Bruyette & Woods cut their price target on Aflac from $125.00 to $120.00 and set a “market perform” rating on the stock in a report on Friday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eight have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $118.73.

Check Out Our Latest Stock Analysis on Aflac

About Aflac

(Get Free Report)

Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.

Recommended Stories

Insider Buying and Selling by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.